Intelligent care navigation combining cognitive testing, neuroimaging, and clinical data to advance how we detect, treat, and understand dementia.
Medotrax delivers integrated digital solutions that connect cognitive assessment, neuroimaging, and patient-reported outcomes across neurology. Our products combine validated testing, clinical data management, and intelligent care navigation - empowering researchers and clinicians to collect, analyze, and act on cognitive health data efficiently and securely.
A clinically validated digital testing app that enables early and objective assessment of cognitive function — bridging research and routine care.
A secure web-based dashboard for clinicians and researchers to manage studies, visualize results, and generate standardized reports.
A digital platform in development to connect diagnostics, imaging, and therapy data — enabling integrated dementia care pathways.
Cloud-based MRI QC & analysis (CogniPATH Imaging Module)
A cloud-based quality control and analysis pipeline for MRI data, designed to standardize imaging workflows across clinics and research partners.
BraincheX has been clinically validated in collaboration with the LMU Hospital Memory Clinic. The digital test battery demonstrated high diagnostic accuracy (AUC = 0.86) and a strong correlation with the CERAD neuropsychological standard (r = 0.73) — confirming its reliability for early detection of cognitive decline.
BraincheX covers all major cognitive domains — including memory, processing speed, cognitive flexibility, spatial orientation, and executive planning — providing a comprehensive digital toolset for modern dementia diagnostics.
Compared to traditional paper-based tests, BraincheX is faster (<15 min), automated, and language-independent, enabling scalable cognitive screening in both clinical and research settings.
| Feature | CERAD‑Plus Paper‑pencil | BraincheX Fully digital |
|---|---|---|
| Domains assessed | Memory, language, visuoconstruction, executive functions | Memory (visual & verbal), processing speed, cognitive flexibility, abstraction |
| Test‑taking time | 30–40 minutes | <15 minutes |
| Administration | Examiner‑administered | Self‑administered with minimal supervision |
| Scoring | Manual scoring; prone to interrater variability | Immediate results calculation |
| Language dependence | Language‑heavy | Language‑independent (e.g., visual memory) |
| Setting | Specialized memory clinics | Scalable, broader, decentralized deployment |
Funded by the Bavarian Ministry of Health and led by LMU Hospital Munich in collaboration with Bavarian State Chamber of Pharmacists, the DARE project brings digital cognitive screening into community pharmacies across Bavaria.
Using the BraincheX app, pharmacists support early detection of cognitive decline and mental health risks, linking patients to medical follow-up and care networks.
Cogscreen II is a joint research project between LMU Klinikum (Department of Psychiatry and Psychotherapy) and Medotrax GmbH, supported by the Davos Alzheimer’s Collaborative (DAC) — a global initiative launched at the World Economic Forum in 2021.
As part of DAC’s Healthcare System Preparedness Program, the project (2024–2026) develops and evaluates scalable digital solutions for early detection and accurate diagnosis of Alzheimer’s disease and related disorders.
BraincheX serves as the core digital cognitive testing platform within this multicenter study, involving primary care physiciancs and neurologists, conducted in collaboration with industry partners including Roche.
Recruitment has begun, marking the start of a global effort to make cognitive screening more accessible, data-driven, and clinically actionable.
Medotrax was founded by clinicians and researchers from LMU Hospital Munich who combine medical expertise with digital innovation to transform dementia diagnostics and care.
Co-Founder & CEO
Medical doctor and neuroscientist at LMU Hospital Munich with expertise in multimodal dementia diagnostics, AI in healthcare and neuroimaging. He combines research and clinical practice to translate evidence-based methods into scalable digital tools for cognitive health.
Co-Founder
Professor of Psychiatric Translational Research in Dementia at LMU Hospital Munich, practicing psychiatrist/geriatrician and an internationally recognized expert in dementia research, diagnostics, and care. A thought leader in the field with deep industry knowledge.
CTO
Digital health engineer and technology strategist, jointly with Boris responsible for the design and development of Medotrax’s digital ecosystem. He leads the implementation of secure, scalable cloud infrastructure and user-centered solutions connecting research and clinical care.
